Browse Category

NASDAQ:KALA News 4 December 2025 - 5 December 2025

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the most volatile biotech penny stocks on the market in late 2025. After a failed eye‑disease trial, a loan default and a near‑miss with foreclosure, the company is now trying to recapitalize itself with fresh equity and new leadership. On December 4, 2025, KALA BIO announced a $10 million registered…
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of news: a $10 million registered direct offering, a loan settlement that turns lender Oxford Finance into a 16.5% shareholder, and…

Stock Market Today

  • Voya Financial Shares Dip Below 200-Day Moving Average, Down Nearly 6%
    February 4, 2026, 12:23 PM EST. Shares of Voya Financial Inc (VOYA) fell below their 200-day moving average of $71.68 on Wednesday, trading as low as $67.97. The stock dropped about 5.8% during the session. The 200-day moving average is a key technical indicator indicating long-term trend. VOYA's 52-week range spans from $52.43 to $79.99, with the last trade near $71.91. This move signals increased selling pressure and potential trend shift for the financial services firm.
Go toTop